EarCalm Spray

EarCalm Spray is a topical treatment designed for the relief of minor outer ear infections, also known as otitis externa. Its active ingredient, acetic acid, acts as an antibacterial agent targeting the bacteria responsible for the infection, thereby alleviating symptoms such as pain and inflammation. The product is available over the counter in pharmacies across the United Kingdom, allowing consumers to access treatment without a prescription. Dexcel Pharma Ltd., the company behind EarCalm, is a privately owned pharmaceutical firm that specializes in the development, manufacturing, and commercialization of both innovative and generic pharmaceutical products worldwide. The company has a diversified portfolio that includes branded prescription drugs, over-the-counter (OTC) products, and generics, catering to various therapeutic areas. Dexcel Pharma Ltd. operates globally, with a significant presence in markets such as the United States, Israel, Germany, the United Kingdom, and Austria. In January 2024, Dexcel Pharma Ltd. expanded its consumer healthcare portfolio in the UK and Ireland by acquiring eight established OTC brands, including EarCalm Spray. This strategic acquisition aimed to strengthen their position in the consumer healthcare market by offering a broader range of products across different therapeutic areas. The company's commitment to innovation and patient care is evident in its continuous efforts to address various health needs through its diverse product offerings.